Alphabet’s venture arm taps biotech veteran to lead life sciences investments

GV, formerly known as Google Ventures, hired biotechnology industry veteran David Schenkein to co-lead the company’s life sciences investments, according to Bloomberg.

Advertisement

Mr. Schenkein previously served as CEO of Agios Pharmaceuticals before stepping down in 2018. He is still chairman of Agios.

GV is the venture capital arm of Google parent Alphabet.

“I can’t think again of any other firm that has as broad a remit in healthcare,” Mr. Schenkein told Bloomberg. “It’s the delivery of healthcare, it’s the insurance of healthcare, it’s healthcare broadly.”

More articles on health IT:
Intermountain, CHIME team up for innovation center
Greenway Health is a 2019 CHIME Innovation Partner
Medecision, SPH Analytics partner to enhance quality measure performance

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.